Medios focuses on specialty pharma, shares on the SDAX radar
30.06.2026 - 09:08:21 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 09:07.
Medios (DE000A1MMCC8) is a German specialty pharmaceutical group with a listing in the SDAX and a focus on individualized therapies for serious diseases. The stock trades in Frankfurt and Xetra, where domestic healthcare plays often attract attention from institutional investors.
What the consensus suggests
Analyst coverage for Medios typically centers on revenue growth from specialty pharmaceuticals and compounding services, as well as margin resilience in a competitive German pharmacy market. The consensus profile usually includes a mix of Buy and Hold ratings that track earnings developments and regulatory changes.
Research houses focusing on German mid caps often look closely at Medios as part of the healthcare and life sciences sector. Their reports tend to highlight the group’s exposure to oncology and other chronic indications, as well as the balance between growth investments and profitability.
Earnings calendar and SDAX role
As an SDAX constituent, Medios follows a regular quarterly reporting cycle that feeds into index-level healthcare statistics. Earnings updates provide data on sales volumes, prescription trends and operating margins, which analysts incorporate into their sector models for German small and mid-cap equities.
The SDAX membership also means Medios shares are included in various index-based products and mandates. For investors, this can translate into additional liquidity when quarterly numbers or guidance adjustments place the stock in the broader German healthcare narrative.
All news and analysis on the Medios shares
Further background, disclosures and price data on Medios can be found in the dedicated topic section and the company’s Investor Relations area.
The product behind the stock
Medios generates revenue primarily through specialty pharmaceutical services, including the procurement and supply of complex medications and the preparation of patient-specific formulations for serious and chronic illnesses. The company’s business model centers on supporting pharmacies and clinics with tailored therapies.
Where the stock trades today
The Medios shares (DE000A1MMCC8) trade on Xetra and the Frankfurt Stock Exchange in euros. At the time of writing, a precise live price and timestamp cannot be stated here, but the listing provides regular intraday quotations for investors following the stock.
Key data on the Medios shares
- Company: Medios AG
- ISIN: DE000A1MMCC8
- WKN: A1MMCC
- Ticker: ME8
- Trading venue: Xetra / Frankfurt
- Price (as of 2026-06-30, 09:07): [live price not specified] euros
- Market cap: [market capitalization not specified] euros (as of 2026-06-30)
- Sector / industry: Healthcare, specialty pharmaceuticals
- Index membership: SDAX
- Next earnings date: not officially scheduled
Disclaimer: This text is for informational purposes only and does not constitute investment advice, buy or sell recommendations, or a solicitation to purchase any financial instrument. All data and assessments are based on publicly available information at the time of review. Investors should conduct their own research or consult independent advisors before making investment decisions.
